<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

    <!-- Primary SEO -->
    <title>How The 4% Project Helps | Year 1 Discovery Plan & Ecosystem Partners</title>
    <meta name="description" content="The 4% Project provides neutral data infrastructure for pediatric cancer advocacy. Learn about our Year 1 discovery plan across academic, pharma, and advocacy tracks ‚Äî and our partnerships with St. Baldrick's, Children's Oncology Group, Kids v. Cancer, and more.">
    <meta name="keywords" content="pediatric cancer advocacy organizations, St Baldricks Foundation, Children's Oncology Group, Kids v Cancer, pediatric oncology policy, childhood cancer data infrastructure, pediatric cancer Year 1 plan">
    <meta name="author" content="The 4% Project">
    <meta name="robots" content="index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1">
    <link rel="canonical" href="https://the4percentproject.org/how-we-help.html">

    <!-- Open Graph -->
    <meta property="og:type" content="article">
    <meta property="og:url" content="https://the4percentproject.org/how-we-help.html">
    <meta property="og:site_name" content="The 4% Project">
    <meta property="og:title" content="How The 4% Project Fills the Gap in Pediatric Cancer Advocacy">
    <meta property="og:description" content="Not another fundraising org. We're data infrastructure ‚Äî building the policy intelligence layer the pediatric oncology ecosystem is missing. See our Year 1 discovery plan and key partners.">
    <meta property="og:image" content="https://images.unsplash.com/photo-1631815588090-d4bfec5b1ccf?w=1200&h=630&fit=crop">
    <meta property="og:image:width" content="1200">
    <meta property="og:image:height" content="630">
    <meta property="og:locale" content="en_US">

    <!-- Twitter / X -->
    <meta name="twitter:card" content="summary_large_image">
    <meta name="twitter:site" content="@4PercentProject">
    <meta name="twitter:title" content="How The 4% Project Fills the Gap in Pediatric Cancer Advocacy">
    <meta name="twitter:description" content="Not another fundraising org. We're data infrastructure ‚Äî building the policy intelligence layer the pediatric oncology ecosystem is missing. See our Year 1 discovery plan and key partners.">
    <meta name="twitter:image" content="https://images.unsplash.com/photo-1631815588090-d4bfec5b1ccf?w=1200&h=630&fit=crop">

    <!-- AEO: Structured Data ‚Äî BreadcrumbList -->
    <script type="application/ld+json">
    {
      "@context": "https://schema.org",
      "@type": "BreadcrumbList",
      "itemListElement": [
        {"@type":"ListItem","position":1,"name":"Home","item":"https://the4percentproject.org/"},
        {"@type":"ListItem","position":2,"name":"How The 4% Project Works: Data Infrastructure for ","item":"https://the4percentproject.org/how-we-help.html"}
      ]
    }
    </script>

    <!-- AEO: Structured Data ‚Äî Article -->
    <script type="application/ld+json">
    {
      "@context": "https://schema.org",
      "@type": "Article",
      "headline": "How The 4% Project Works: Data Infrastructure for Pediatric Cancer Advocacy",
      "description": "The 4% Project provides neutral data infrastructure for pediatric cancer advocacy. Learn about our Year 1 discovery plan across academic, pharma, and advocacy tracks ‚Äî and our partnerships with St. Baldrick's, Children's Oncology Group, Kids v. Cancer, and more.",
      "url": "https://the4percentproject.org/how-we-help.html",
      "publisher": {
        "@type": "Organization",
        "name": "The 4% Project",
        "url": "https://the4percentproject.org"
      },
      "dateModified": "2026-02-23"
    }
    </script>

    <!-- AEO: Structured Data ‚Äî FAQPage -->
    <script type="application/ld+json">
    {
      "@context": "https://schema.org",
      "@type": "FAQPage",
      "mainEntity": [
        {"@type":"Question","name":"What does The 4% Project do?","acceptedAnswer":{"@type":"Answer","text":"The 4% Project is a Public Benefit Corporation that provides data analysis, legislative intelligence, and policy consulting to the pediatric cancer advocacy ecosystem. Rather than duplicating existing fundraising efforts, it builds neutral data infrastructure that helps established organizations like St. Baldrick's Foundation, the Children's Oncology Group, and Kids v. Cancer be more effective."}},
        {"@type":"Question","name":"What is The 4% Project's Year 1 plan?","acceptedAnswer":{"@type":"Answer","text":"The 4% Project's first year is structured as a discovery phase across three parallel tracks: Academic & Clinical Institutions (fellowships, physician pipeline, research gaps), Pharmaceutical Industry (drug pipeline, PRV program utilization, trial design), and Advocacy Organizations (legislative gaps, data infrastructure needs). The quarter-by-quarter roadmap prioritizes listening and ecosystem mapping before committing to specific technology products."}},
        {"@type":"Question","name":"How is The 4% Project funded?","acceptedAnswer":{"@type":"Answer","text":"The 4% Project is supported by Kingdom of Impact, a mission-driven Donor Advised Fund, through a Program-Related Investment structure. It operates as a Public Benefit Corporation, enabling it to pursue mission-driven work while building sustainable revenue streams including data licensing, SaaS subscriptions, consulting, and sponsored research reports."}}
      ]
    }
    </script>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Libre+Baskerville:wght@400;700&family=Work+Sans:wght@300;400;500;600;700&display=swap" rel="stylesheet">
    <style>
        * { margin:0; padding:0; box-sizing:border-box; }
        :root {
            --primary:#d62828; --primary-dark:#9d0208; --primary-light:#f77f00;
            --accent:#003049; --accent-light:#669bbc;
            --text-dark:#1a1a1a; --text-gray:#4a4a4a;
            --bg-cream:#fdfcf8; --bg-light:#ffffff;
            --border:#e8e4dc; --shadow:rgba(0,0,0,0.08);
        }
        body { font-family:'Work Sans',sans-serif; line-height:1.6; color:var(--text-dark); background:var(--bg-cream); overflow-x:hidden; }
        h1,h2,h3,h4,h5,h6 { font-family:'Libre Baskerville',serif; line-height:1.2; font-weight:700; }
        nav { background:var(--bg-light); box-shadow:0 2px 10px var(--shadow); position:sticky; top:0; z-index:1000; }
        .nav-container { max-width:1200px; margin:0 auto; padding:1rem 2rem; display:flex; justify-content:space-between; align-items:center; }
        .logo { font-family:'Libre Baskerville',serif; font-size:1.5rem; font-weight:700; color:var(--primary); text-decoration:none; }
        .nav-links { display:flex; gap:2rem; list-style:none; }
        .nav-links a { color:var(--text-dark); text-decoration:none; font-weight:500; transition:color 0.3s ease; }
        .nav-links a:hover { color:var(--primary); }
        .nav-links a.active { color:var(--primary); border-bottom:2px solid var(--primary); }
        .mobile-menu-btn { display:none; background:none; border:none; font-size:1.5rem; cursor:pointer; }
        .container { max-width:1200px; margin:0 auto; padding:0 2rem; }
        .page-hero { background:linear-gradient(135deg,rgba(0,48,73,0.95) 0%,rgba(102,155,188,0.92) 100%); color:white; padding:5rem 2rem 4rem; }
        .page-hero h1 { font-size:clamp(2rem,4vw,3rem); margin-bottom:1rem; }
        .page-hero p { font-size:1.2rem; font-weight:300; max-width:700px; opacity:0.9; }
        section { padding:5rem 0; }
        .section-header { text-align:center; margin-bottom:4rem; }
        .section-header h2 { font-size:clamp(1.8rem,3vw,2.5rem); margin-bottom:1rem; color:var(--accent); }
        .section-header p { font-size:1.1rem; color:var(--text-gray); max-width:700px; margin:0 auto; }
        .card { background:white; border-radius:16px; padding:2.5rem; box-shadow:0 4px 20px var(--shadow); margin-bottom:2rem; border-top:4px solid var(--primary); }
        .card h3 { font-size:1.4rem; color:var(--accent); margin-bottom:1rem; }
        .card p { color:var(--text-gray); margin-bottom:1rem; }
        .icon { font-size:2.5rem; margin-bottom:1rem; display:block; }
        .data-grid { display:grid; grid-template-columns:repeat(auto-fit,minmax(280px,1fr)); gap:2rem; margin:3rem 0; }
        .callout { background:#fff3cd; border-left:4px solid var(--primary-light); padding:1.5rem 2rem; border-radius:8px; margin:2rem 0; }
        .callout p { font-weight:600; color:var(--text-dark); font-size:1.05rem; }
        .btn { display:inline-block; padding:0.85rem 1.75rem; border-radius:50px; font-weight:600; text-decoration:none; transition:all 0.3s ease; font-size:0.95rem; }
        .btn-primary { background:var(--primary); color:white; }
        .btn-primary:hover { background:var(--primary-dark); transform:translateY(-2px); }
        .btn-outline { background:transparent; color:var(--accent); border:2px solid var(--accent); }
        .btn-outline:hover { background:var(--accent); color:white; transform:translateY(-2px); }
        .btn-white { background:white; color:var(--accent); }
        .btn-white:hover { background:#f0f0f0; transform:translateY(-2px); }

        /* Year 1 Plan */
        .year1-section { background:white; border-radius:20px; padding:3.5rem; box-shadow:0 4px 20px var(--shadow); margin:3rem 0; }
        .year1-section h3 { font-size:1.8rem; color:var(--accent); margin-bottom:0.5rem; }
        .year1-section .sub { color:var(--text-gray); font-size:1rem; margin-bottom:3rem; }
        .track-grid { display:grid; grid-template-columns:repeat(3,1fr); gap:2rem; margin-bottom:3rem; }
        .track { border-radius:14px; padding:2rem; }
        .track.academic { background:linear-gradient(135deg,#f0f6ff,#e0eeff); border-top:4px solid var(--accent); }
        .track.pharma { background:linear-gradient(135deg,#fff7f0,#ffe8d6); border-top:4px solid var(--primary-light); }
        .track.advocacy { background:linear-gradient(135deg,#f0fff4,#d8f3dc); border-top:4px solid #2d6a4f; }
        .track-label { font-size:0.75rem; font-weight:700; text-transform:uppercase; letter-spacing:1px; margin-bottom:0.5rem; }
        .track.academic .track-label { color:var(--accent); }
        .track.pharma .track-label { color:var(--primary-light); }
        .track.advocacy .track-label { color:#2d6a4f; }
        .track h4 { font-size:1.1rem; color:var(--text-dark); margin-bottom:1rem; }
        .track ul { list-style:none; }
        .track ul li { font-size:0.9rem; color:var(--text-gray); padding:0.4rem 0; border-bottom:1px solid rgba(0,0,0,0.06); display:flex; gap:0.5rem; }
        .track ul li:last-child { border-bottom:none; }
        .track ul li::before { content:'‚Üí'; flex-shrink:0; opacity:0.5; }
        .quarters { display:grid; grid-template-columns:repeat(4,1fr); gap:1rem; }
        .quarter { border-radius:12px; padding:1.5rem; background:#f8f9fa; border-left:4px solid var(--accent-light); }
        .quarter-label { font-size:0.75rem; font-weight:700; text-transform:uppercase; color:var(--accent); letter-spacing:0.5px; margin-bottom:0.75rem; }
        .quarter h5 { font-size:0.95rem; color:var(--text-dark); margin-bottom:0.5rem; }
        .quarter p { font-size:0.83rem; color:var(--text-gray); line-height:1.5; }
        .year1-note { background:var(--accent); color:white; border-radius:14px; padding:2rem; margin-top:2.5rem; }
        .year1-note p { opacity:0.92; font-size:0.95rem; line-height:1.7; }
        .year1-note strong { color:#93c5fd; }

        /* Ecosystem partners */
        .partner-grid { display:grid; grid-template-columns:repeat(auto-fit,minmax(260px,1fr)); gap:1.5rem; margin:2.5rem 0; }
        .partner-card { background:white; border-radius:14px; padding:2rem; box-shadow:0 4px 20px var(--shadow); border-left:4px solid var(--accent-light); transition:transform 0.25s ease; }
        .partner-card:hover { transform:translateY(-3px); }
        .partner-card h4 { font-size:1.05rem; color:var(--accent); margin-bottom:0.5rem; }
        .partner-card p { font-size:0.88rem; color:var(--text-gray); margin-bottom:1rem; line-height:1.6; }
        .partner-link { font-size:0.85rem; font-weight:600; color:var(--primary); text-decoration:none; display:inline-flex; align-items:center; gap:0.3rem; }
        .partner-link:hover { color:var(--primary-dark); }

        /* PBC Note */
        .pbc-note { background:var(--accent); color:white; border-radius:16px; padding:3rem; margin:3rem 0; }
        .pbc-note h3 { font-size:1.8rem; margin-bottom:1rem; }
        .pbc-note p { opacity:0.9; font-size:1.05rem; margin-bottom:1rem; line-height:1.7; }

        footer { background:var(--accent); color:white; padding:3rem 2rem; text-align:center; }
        footer a { color:var(--primary-light); text-decoration:none; }
        @media (max-width:900px) { .track-grid { grid-template-columns:1fr; } .quarters { grid-template-columns:1fr 1fr; } }
        @media (max-width:768px) {
            .nav-links { display:none; } .mobile-menu-btn { display:block; }
            .data-grid { grid-template-columns:1fr; }
            .year1-section { padding:2rem; }
            .quarters { grid-template-columns:1fr; }
        }
    </style>
</head>
<body>
<nav>
    <div class="nav-container">
        <a href="index.html" class="logo">The 4% Project</a>
        <ul class="nav-links">
            <li><a href="index.html">Home</a></li>
            <li><a href="funding-discrepancy.html">Funding Crisis</a></li>
            <li><a href="doctor-pay.html">Doctor Pay Gap</a></li>
            <li><a href="legislation.html">Legislation & Lobbying</a></li>
            <li><a href="how-we-help.html" class="active">How We Help</a></li>
        </ul>
        <button class="mobile-menu-btn">‚ò∞</button>
    </div>
</nav>

<main>
    <div class="page-hero">
        <div class="container">
            <h1>How We Help</h1>
            <p>The 4% Project is data infrastructure and policy intelligence for the pediatric cancer ecosystem‚Äîamplifying the work of existing organizations, not competing with it.</p>
        </div>
    </div>

    <section>
        <div class="container">
            <div class="section-header">
                <h2>Our Role in the Ecosystem</h2>
                <p>We exist to fill a specific, critical gap: neutral, policy-focused data analysis that translates research into legislative action</p>
            </div>

            <div class="callout">
                <p>The pediatric oncology ecosystem already has excellent researchers, passionate advocates, and dedicated clinicians. What it lacks is neutral data infrastructure that bridges research, policy, and public awareness. That's exactly what we're building.</p>
            </div>

            <div class="data-grid">
                <div class="card">
                    <span class="icon">üìä</span>
                    <h3>Data Analysis & Reporting</h3>
                    <p>We compile, analyze, and publish accessible reports on funding disparities, physician compensation gaps, drug development timelines, and legislative progress‚Äîmaking complex policy data understandable and actionable.</p>
                </div>
                <div class="card">
                    <span class="icon">üèõÔ∏è</span>
                    <h3>Legislative Intelligence</h3>
                    <p>We track relevant legislation across all 50 states and in Congress, providing the pediatric oncology community with real-time updates on bills, amendments, committee activity, and advocacy opportunities.</p>
                </div>
                <div class="card">
                    <span class="icon">ü§ù</span>
                    <h3>Ecosystem Collaboration</h3>
                    <p>We work alongside St. Baldrick's Foundation, the Children's Oncology Group, and other established organizations‚Äîproviding data tools and policy analysis that amplify their existing advocacy efforts.</p>
                </div>
                <div class="card">
                    <span class="icon">üì¢</span>
                    <h3>Public Awareness</h3>
                    <p>Through this platform, media partnerships, and community outreach, we translate the funding crisis into terms that move the public‚Äîand their representatives‚Äîto act.</p>
                </div>
                <div class="card">
                    <span class="icon">üî¨</span>
                    <h3>Research Partnership</h3>
                    <p>We connect pharmaceutical companies, academic medical centers, and research institutions with data on pediatric oncology needs, helping identify where industry investment can have maximum impact.</p>
                </div>
                <div class="card">
                    <span class="icon">üí°</span>
                    <h3>Policy Consulting</h3>
                    <p>For organizations seeking to navigate the legislative landscape around pediatric cancer, we provide research-backed policy analysis and strategic guidance.</p>
                </div>
            </div>

            <!-- YEAR 1 PLAN -->
            <div class="year1-section">
                <h3>Year 1: Discovery Before Technology</h3>
                <p class="sub">Before we build, we listen. Our entire first year is structured as a systematic discovery phase across three parallel tracks‚Äîunderstanding the ecosystem's needs before committing to any specific product or service.</p>

                <div class="track-grid">
                    <div class="track academic">
                        <div class="track-label">Track 1</div>
                        <h4>Academic & Clinical Institutions</h4>
                        <ul>
                            <li>Fellowship programs at MUSC, Dana-Farber, Texas Children's, St. Jude</li>
                            <li>Interview attending physicians on data needs and research gaps</li>
                            <li>Map compensation structures and training pipelines</li>
                            <li>Identify which institutions are most data-constrained</li>
                            <li>Explore LOI potential for physician loan programs</li>
                        </ul>
                    </div>
                    <div class="track pharma">
                        <div class="track-label">Track 2</div>
                        <h4>Pharmaceutical Industry</h4>
                        <ul>
                            <li>Map pediatric oncology pipeline across major and specialty pharma</li>
                            <li>Interview R&D teams on PRV program utilization post-Give Kids a Chance Act</li>
                            <li>Assess willingness to fund sponsored research reports</li>
                            <li>Identify where data gaps slow pediatric trial design</li>
                            <li>Explore partnership on RACE Act compliance support</li>
                        </ul>
                    </div>
                    <div class="track advocacy">
                        <div class="track-label">Track 3</div>
                        <h4>Advocacy Organizations</h4>
                        <ul>
                            <li>Meet with St. Baldrick's, Children's Cancer Cause, Kids v. Cancer</li>
                            <li>Understand where policy intelligence is currently lacking</li>
                            <li>Map legislative tracking capabilities across the sector</li>
                            <li>Assess appetite for shared data infrastructure vs. proprietary tools</li>
                            <li>Identify complementary vs. overlapping roles</li>
                        </ul>
                    </div>
                </div>

                <h4 style="font-size:1.2rem;color:var(--accent);margin-bottom:1.5rem;">Quarter-by-Quarter Discovery Roadmap</h4>
                <div class="quarters">
                    <div class="quarter">
                        <div class="quarter-label">Q1 ‚Äî Months 1‚Äì3</div>
                        <h5>Ecosystem Mapping</h5>
                        <p>Build comprehensive map of all organizations, key stakeholders, funding flows, and legislative touchpoints. Establish first meetings with each of the three tracks.</p>
                    </div>
                    <div class="quarter">
                        <div class="quarter-label">Q2 ‚Äî Months 4‚Äì6</div>
                        <h5>Deep Listening</h5>
                        <p>Conduct structured interviews across 20+ organizations. Document pain points, data needs, and unmet opportunities. Begin publishing initial research reports.</p>
                    </div>
                    <div class="quarter">
                        <div class="quarter-label">Q3 ‚Äî Months 7‚Äì9</div>
                        <h5>Opportunity Validation</h5>
                        <p>Synthesize findings. Test hypotheses about highest-leverage products with potential partners. Identify 2‚Äì3 specific data infrastructure gaps to pursue. Seek early LOIs.</p>
                    </div>
                    <div class="quarter">
                        <div class="quarter-label">Q4 ‚Äî Months 10‚Äì12</div>
                        <h5>Year 2 Strategy</h5>
                        <p>Define the product and service roadmap based on validated discovery. Secure first pilot partnerships. Build the foundation for technology enablement in Year 2.</p>
                    </div>
                </div>

                <div class="year1-note">
                    <p><strong>Why discovery first?</strong> The pediatric oncology ecosystem is deeply relationship-driven and has seen many well-intentioned new entrants come and go. Trust is built over time, not announced. By spending Year 1 in deep listening mode‚Äîunderstanding what the ecosystem actually needs rather than what we assume it needs‚Äîwe dramatically increase the likelihood that the technology and tools we build in Year 2 will be adopted, valued, and sustainable. <strong>This is how infrastructure gets built that lasts.</strong></p>
                </div>
            </div>

            <!-- ECOSYSTEM PARTNERS -->
            <div class="section-header" style="margin-top:5rem;">
                <h2>Organizations We Work With</h2>
                <p>The 4% Project complements‚Äînever competes with‚Äîthese established players. Our role is to provide data infrastructure and policy intelligence that makes their work more effective.</p>
            </div>

            <div class="partner-grid">
                <div class="partner-card">
                    <h4>St. Baldrick's Foundation</h4>
                    <p>The largest private funder of childhood cancer research grants. St. Baldrick's has awarded over $300M in research funding. We provide policy intelligence and funding data analysis to amplify their advocacy.</p>
                    <a href="https://www.stbaldricks.org" target="_blank" class="partner-link">stbaldricks.org ‚Üí</a>
                </div>
                <div class="partner-card">
                    <h4>Children's Oncology Group (COG)</h4>
                    <p>The world's largest organization devoted exclusively to childhood and adolescent cancer research. COG coordinates clinical trials at 200+ institutions. We track their trial data needs and policy landscape.</p>
                    <a href="https://childrensoncologygroup.org" target="_blank" class="partner-link">childrensoncologygroup.org ‚Üí</a>
                </div>
                <div class="partner-card">
                    <h4>Kids v. Cancer</h4>
                    <p>The legislative advocacy organization behind the Give Kids a Chance Act‚Äîthe law signed February 3, 2026. Led by Nancy Goodman, they represent the gold standard for pediatric cancer legislative strategy.</p>
                    <a href="https://kidsvcancer.org" target="_blank" class="partner-link">kidsvcancer.org ‚Üí</a>
                </div>
                <div class="partner-card">
                    <h4>Children's Cancer Cause</h4>
                    <p>A leading childhood cancer policy organization that works to improve outcomes through advocacy, education, and survivorship programs. Tracks legislation across the full pediatric cancer policy spectrum.</p>
                    <a href="https://www.childrenscancercause.org" target="_blank" class="partner-link">childrenscancercause.org ‚Üí</a>
                </div>
                <div class="partner-card">
                    <h4>Alex's Lemonade Stand Foundation</h4>
                    <p>Funds cutting-edge childhood cancer research and raises awareness. ALSF has funded over $250M in research grants. A key research funder in the ecosystem alongside St. Baldrick's.</p>
                    <a href="https://www.alexslemonade.org" target="_blank" class="partner-link">alexslemonade.org ‚Üí</a>
                </div>
                <div class="partner-card">
                    <h4>National Cancer Institute (NCI)</h4>
                    <p>The federal agency that administers cancer research funding‚Äîincluding the current 4% allocation for pediatric cancers. NCI's Childhood Cancer Data Initiative is a key data resource for our analysis work.</p>
                    <a href="https://www.cancer.gov/research/areas/childhood" target="_blank" class="partner-link">cancer.gov/childhood ‚Üí</a>
                </div>
                <div class="partner-card">
                    <h4>St. Jude Children's Research Hospital</h4>
                    <p>Globally recognized leader in pediatric cancer treatment and research. St. Jude shares its research and clinical data freely with the world‚Äîa model for open science in pediatric oncology.</p>
                    <a href="https://www.stjude.org" target="_blank" class="partner-link">stjude.org ‚Üí</a>
                </div>
                <div class="partner-card">
                    <h4>Pediatric Cancer Research Foundation</h4>
                    <p>Funds pediatric cancer research with a focus on diseases that receive the least federal support. A critical partner for understanding where private funding fills gaps left by the 4% funding floor.</p>
                    <a href="https://pcrf-kids.org" target="_blank" class="partner-link">pcrf-kids.org ‚Üí</a>
                </div>
            </div>

            <!-- PBC Note -->
            <div class="pbc-note">
                <h3>Funded Through Kingdom of Impact</h3>
                <p>The 4% Project is supported by Kingdom of Impact, a mission-driven Donor Advised Fund committed to advancing healthcare equity for vulnerable populations. Our Program-Related Investment enables us to operate as a Public Benefit Corporation‚Äîmission-driven from day one.</p>
                <p>We are not a fundraising organization competing with direct service charities. We are infrastructure. Structured as a PBC, we can pursue mission-driven work while building sustainable revenue streams‚Äîdata licensing, SaaS subscriptions, consulting, and sponsored research‚Äîthat allow us to scale without perpetual fundraising dependence. Our long-term interests are aligned with the ecosystem, not with any single donor or political agenda.</p>
                <a href="mailto:contact@the4percentproject.org" class="btn btn-white" style="margin-top:0.5rem;">Get In Touch ‚Üí</a>
            </div>
        </div>
    </section>
</main>

<footer>
    <div class="container">
        <p style="font-weight:600;font-size:1.1rem;margin-bottom:1rem;">Let's put a dent in the universe. Together.</p>
        <p>¬© 2026 The 4% Project | Fighting for fair funding in pediatric cancer research</p>
    </div>
</footer>
</body>
</html>
